Your browser doesn't support javascript.
loading
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.
Zhuang, Chun-Lan; Lin, Zhi-Jie; Bi, Zhao-Feng; Qiu, Ling-Xian; Hu, Fang-Fang; Liu, Xiao-Hui; Lin, Bi-Zhen; Su, Ying-Ying; Pan, Hui-Rong; Zhang, Tian-Ying; Huang, Shou-Jie; Hu, Yue-Mei; Qiao, You-Lin; Zhu, Feng-Cai; Wu, Ting; Zhang, Jun; Xia, Ning-Shao.
Afiliación
  • Zhuang CL; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
  • Lin ZJ; Xiamen Innovax Biotech CO., Ltd., Xiamen, People's Republic of China.
  • Bi ZF; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
  • Qiu LX; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
  • Hu FF; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
  • Liu XH; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
  • Lin BZ; Xiamen Innovax Biotech CO., Ltd., Xiamen, People's Republic of China.
  • Su YY; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
  • Pan HR; Xiamen Innovax Biotech CO., Ltd., Xiamen, People's Republic of China.
  • Zhang TY; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
  • Huang SJ; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
  • Hu YM; Jiangsu Provincial Center for Disease Control and Prevention, Public Health research institute of Jiangsu Province, Nanjing, People's Republic of China.
  • Qiao YL; Chinese Academy of Medical Sciences/Peking Union Medical College School of Population Medicine and Public Health, Beijing, People's Republic of China.
  • Zhu FC; Jiangsu Provincial Center for Disease Control and Prevention, Public Health research institute of Jiangsu Province, Nanjing, People's Republic of China.
  • Wu T; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
  • Zhang J; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
  • Xia NS; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, People's Republic of
Emerg Microbes Infect ; 10(1): 365-375, 2021 Dec.
Article en En | MEDLINE | ID: mdl-33583360
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra Hepatitis Viral / Vacunas Sintéticas / Hepatitis E / Infecciones por Papillomavirus / Papillomavirus Humano 16 / Papillomavirus Humano 18 / Vacunas contra Papillomavirus Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Emerg Microbes Infect Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra Hepatitis Viral / Vacunas Sintéticas / Hepatitis E / Infecciones por Papillomavirus / Papillomavirus Humano 16 / Papillomavirus Humano 18 / Vacunas contra Papillomavirus Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Emerg Microbes Infect Año: 2021 Tipo del documento: Article